Home » Mr Will Delaat

Mr Will Delaat

[vc_row font_color=”” background_style=”normal”][vc_column][vc_row_inner type=”boxed” css=”.vc_custom_1425510912116{padding-top: 30px !important;}”][vc_column_inner][vc_single_image image=”26141″ alignment=”center”][vc_column_text]

Mr Will Delaat

EnGeneIC Board Member

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner type=”boxed” css=”.vc_custom_1425511357127{padding-bottom: 80px !important;}”][vc_column_inner width=”1/6″][vc_empty_space height=”1″][/vc_column_inner][vc_column_inner width=”2/3″][vc_column_text]

Will has spent almost 40 years in the Pharmaceutical Industry, working as a senior executive in Sales, Marketing and Business Development roles, and for 11 years as Managing Director of Merck, Sharp & Dohme (Australia/NZ) before retiring in 2008. Will was the Independent Chairman of Medicines Australia, the peak body representing the innovative pharmaceuticals industry in Australia until December 2011, and subsequently has joined the Boards, as a non-executive Director, of Pharmaxis Pty Ltd and iNova Pharmaceuticals Pty Ltd. He has also been the Chairman of the Pharmaceuticals Industry Council, and a member of the Fragile X Association of Australia Board, and the Return of Unwanted Medicines (RUM) Board.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row font_color=”” css=”.vc_custom_1439784689791{padding-top: 60px !important;padding-bottom: 60px !important;background-color: #99bbcc !important;}”][vc_column][vc_row_inner type=”boxed”][vc_column_inner width=”3/4″][vc_column_text]

Meet the People Behind EnGeneIC

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/4″][vc_btn title=”OUR PEOPLE” color=”white” align=”center” link=”url:http%3A%2F%2Fengeneic.azurewebsites.net%2Four-people%2F|title:Our%20People|” button_block=”true”][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]